• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲型 H5N1 流感病毒灭活疫苗对 1 型糖尿病小鼠感染的疗效。

Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes.

机构信息

College of Life Sciences, Hunan Normal University, Changsha 410081, Hunan, China.

出版信息

Vaccine. 2010 Mar 24;28(15):2775-81. doi: 10.1016/j.vaccine.2010.01.037. Epub 2010 Jan 29.

DOI:10.1016/j.vaccine.2010.01.037
PMID:20117261
Abstract

We sought to determine susceptibility to highly pathogenic avian influenza (HPAI) H5N1 virus and to explore immune protection of inactivated H5N1 vaccine in streptozotocin-induced type 1 diabetic mice. Susceptibility of diabetic mice to an H5N1 virus was evaluated by comparing the median lethal dose (LD(50)) and the lung virus titers with those of the healthy after the viral infection. To evaluate the influence of diabetes on vaccination, diabetic and healthy mice were immunized once with an inactivated H5N1 vaccine and then challenged with a lethal dose of H5N1 virus. The antibody responses, survival rates, lung virus titers and body weight changes were tested. Mice with type 1 diabetes had higher lung virus titers and lower survival rates than healthy mice after H5N1 virus infection. Inactivated H5N1 vaccine induced protective antibody in diabetic mice, but the antibody responses were postponed and weakened. In spite of this, diabetic mice could be protected against the lethal virus challenge by a single dose of immunization when the amount of the antigen increased. These results indicated that type 1 diabetic mice were more susceptible to H5N1 influenza virus infection than healthy mice, and can be effectively protected by inactivated H5N1 vaccine with increased antigen.

摘要

我们旨在确定对高致病性禽流感(HPAI)H5N1 病毒的易感性,并探索灭活 H5N1 疫苗对 1 型糖尿病小鼠的免疫保护作用。通过比较感染病毒后健康小鼠和糖尿病小鼠的半数致死剂量(LD(50))和肺部病毒滴度来评估糖尿病小鼠对 H5N1 病毒的易感性。为了评估糖尿病对疫苗接种的影响,将糖尿病和健康小鼠用灭活的 H5N1 疫苗免疫一次,然后用致死剂量的 H5N1 病毒进行攻毒。检测了抗体反应、存活率、肺部病毒滴度和体重变化。与健康小鼠相比,1 型糖尿病小鼠在感染 H5N1 病毒后肺部病毒滴度更高,存活率更低。灭活的 H5N1 疫苗在糖尿病小鼠中诱导了保护性抗体,但抗体反应被推迟和减弱。尽管如此,当抗原量增加时,一剂免疫接种仍可使糖尿病小鼠免受致命病毒攻击的保护。这些结果表明,1 型糖尿病小鼠比健康小鼠更容易感染 H5N1 流感病毒,并且可以通过增加抗原的灭活 H5N1 疫苗得到有效保护。

相似文献

1
Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes.甲型 H5N1 流感病毒灭活疫苗对 1 型糖尿病小鼠感染的疗效。
Vaccine. 2010 Mar 24;28(15):2775-81. doi: 10.1016/j.vaccine.2010.01.037. Epub 2010 Jan 29.
2
Superior protection provided by a single dose of MF59-adjuvanted whole inactivated H5N1 influenza vaccine in type 1 diabetic mice.MF59 佐剂全灭活 H5N1 流感疫苗在 1 型糖尿病小鼠中提供的优越保护。
Arch Virol. 2011 Mar;156(3):387-95. doi: 10.1007/s00705-010-0860-4. Epub 2010 Nov 26.
3
Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.通过鼻内共同给予杆状病毒表面展示的血凝素(HA)和重组霍乱毒素B亚单位(CTB)作为佐剂,对小鼠进行针对H5N1流感病毒攻击的保护性免疫。
Virology. 2008 Oct 25;380(2):412-20. doi: 10.1016/j.virol.2008.08.002. Epub 2008 Sep 10.
4
Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant.壳聚糖作为佐剂经鼻腔给予 M2 基疫苗对流感病毒感染的交叉保护作用。
Arch Virol. 2010 Apr;155(4):535-44. doi: 10.1007/s00705-010-0621-4. Epub 2010 Feb 27.
5
Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model.含铝佐剂的灭活H5N1全病毒疫苗在小鼠模型中可诱导针对高致病性H5N1禽流感病毒致死性攻击的同源和异源保护性免疫。
Vaccine. 2007 May 4;25(18):3554-60. doi: 10.1016/j.vaccine.2007.01.083. Epub 2007 Jan 30.
6
Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice.灭活及佐剂全病毒 2.3.4 分支 H5N1 大流行前流感疫苗在小鼠中对异源高致病性 H5N1 禽流感病毒具有广泛的保护效力。
Vaccine. 2011 Oct 26;29(46):8330-7. doi: 10.1016/j.vaccine.2011.08.091. Epub 2011 Sep 10.
7
Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.鼻内疫苗用蘑菇菌丝体提取物诱导针对甲型流感病毒 H5N1 的交叉保护免疫。
J Med Virol. 2010 Jan;82(1):128-37. doi: 10.1002/jmv.21670.
8
Investigation of the biological indicator for vaccine efficacy against highly pathogenic avian influenza (HPAI) H5N1 virus challenge in mice and ferrets.针对小鼠和雪貂感染高致病性禽流感(HPAI)H5N1病毒的疫苗效力的生物学指标研究。
Vaccine. 2009 May 21;27(24):3145-52. doi: 10.1016/j.vaccine.2009.03.061. Epub 2009 Apr 9.
9
A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.一种由非致病性H5N1禽流感病毒株制备的疫苗可使食蟹猕猴对高致病性禽流感病毒感染产生保护性免疫。
Vaccine. 2008 Jan 24;26(4):562-72. doi: 10.1016/j.vaccine.2007.11.031. Epub 2007 Dec 3.
10
Protection of pregnant mice, fetuses and neonates from lethality of H5N1 influenza viruses by maternal vaccination.通过母体接种保护怀孕小鼠、胎儿和新生儿免受 H5N1 流感病毒的致死性影响。
Vaccine. 2010 Apr 9;28(17):2957-64. doi: 10.1016/j.vaccine.2010.02.016. Epub 2010 Feb 25.

引用本文的文献

1
Respiratory Tract Infections in Diabetes - Lessons From Tuberculosis and Influenza to Guide Understanding of COVID-19 Severity.糖尿病患者的呼吸道感染——从结核病和流感中汲取的经验教训,以指导对新冠病毒疾病严重程度的理解
Front Endocrinol (Lausanne). 2022 Jul 26;13:919223. doi: 10.3389/fendo.2022.919223. eCollection 2022.
2
Virus Infections and Host Metabolism-Can We Manage the Interactions?病毒感染与宿主代谢——我们能否控制相互作用?
Front Immunol. 2021 Feb 3;11:594963. doi: 10.3389/fimmu.2020.594963. eCollection 2020.
3
Glycemic Variability in Diabetes Increases the Severity of Influenza.
糖尿病患者的血糖波动会加重流感的严重程度。
mBio. 2020 Mar 24;11(2):e02841-19. doi: 10.1128/mBio.02841-19.
4
Influenza in High-Risk Hosts-Lessons Learned from Animal Models.高危宿主中的流感——从动物模型中获得的经验教训。
Cold Spring Harb Perspect Med. 2020 Dec 1;10(12):a038604. doi: 10.1101/cshperspect.a038604.
5
Influenza Virus and Glycemic Variability in Diabetes: A Killer Combination?流感病毒与糖尿病患者的血糖变异性:致命组合?
Front Microbiol. 2017 May 22;8:861. doi: 10.3389/fmicb.2017.00861. eCollection 2017.
6
Pathology of Equine Influenza virus (H3N8) in Murine Model.马流感病毒(H3N8)在小鼠模型中的病理学
PLoS One. 2015 Nov 20;10(11):e0143094. doi: 10.1371/journal.pone.0143094. eCollection 2015.
7
A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus.基于保守的 H5N1 亚型蛋白的单次 DNA 疫苗接种可预防先前暴露于 H1N1 流感病毒的小鼠免受致死性 H5N1 挑战的侵害。
Virol J. 2010 Aug 21;7:197. doi: 10.1186/1743-422X-7-197.